Investigating nucleo-cytoplasmic partitioning in Alzheimer's disease and aging

研究阿尔茨海默病和衰老中的核质分配

基本信息

  • 批准号:
    10042748
  • 负责人:
  • 金额:
    $ 19.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Nucleo-cytoplasmic partitioning of proteins is an emerging intracellular process with crucial roles in Alzheimer’s disease and aging. Karyopherins mediate proper partitioning by transporting proteins across the nuclear pore. Pharmacological modulation of karyopherins provides a new approach for therapies against Alzheimer’s disease. Recent studies in model organisms and mammalian cells have uncovered that several neurodegenerative diseases display dysfunctional nucleo-cytoplasmic protein partitioning. We have reported that the conserved karyopherin XPO1 accelerates aging by promoting the nuclear export of longevity-associated transcription factors, thereby preventing the maintenance of proteostatic mechanisms. Specifically, we showed that inhibiting XPO1 leads to lifespan extensions and results in enhanced proteostasis across phyla, in part via the autophagy- lysosomal pathway. Levels of XPO1 are reduced in long-lived animals and our recent data suggest that XPO1-mediated lifespan modulation relies on fundamental changes in transcriptome and proteome partitioning as well as nucleoli re-organization, which results in altered ribosomal biogenesis. Thus, we hypothesize that XPO1 coordinately modulates the nucleo-cytoplasmic partitioning of proteins and nucleoli formation, thereby regulating compartment-specific protein functions, ribosomal biogenesis, active mRNA translation and consequently lifespan. To address this hypothesis, we propose to conduct a global characterization of protein partitioning and specification and its impact on proteostasis and aging. We will combine cutting- edge genetics and biochemical approaches in C. elegans and mammalian cells to characterize the nucleo-cytoplasmic partitioning of proteins during aging (Aim 1) and, ultimately, to uncover new modulators of nucleolar function with potential benefits against Alzheimer’s disease (Aim 2). These proposed studies are significant as they address an important question in aging related to the role and regulation of nucleo-cytoplasmic partitioning and nucleoli function during organism aging. Our approaches are innovative since we utilize C. elegans and mammalian cells in parallel to quickly identify specific protein translation and partitioning of proteins with roles in aging and to uncover pharmacological strategies to modulate nucleolar and ribosomal dynamics and preventing Alzheimer’s disease.
项目总结/摘要 蛋白质的核质分配是一个新兴的细胞内过程, 老年痴呆症和衰老核转运蛋白通过转运介导适当的分配 蛋白质穿过核孔。核转运蛋白的药理学调节提供了一种新的 治疗阿尔茨海默病的方法。 最近对模式生物和哺乳动物细胞的研究发现, 神经变性疾病显示出功能失调的核质蛋白质分配。我们 据报道,保守的karyopherin XPO 1通过促进细胞核内 长寿相关转录因子的输出,从而防止 蛋白质抑制机制具体来说,我们发现,抑制XPO 1导致寿命延长, 延伸并导致跨门增强的蛋白质稳态,部分通过自噬- 溶酶体途径XPO 1的水平在长寿动物中降低,我们最近的数据显示, 表明XPO 1介导的寿命调节依赖于转录组的基本变化, 蛋白质组分配以及核仁重组,这导致核糖体改变, 生物起源因此,我们假设XPO 1协调调节细胞核-细胞质 蛋白质分配和核仁形成,从而调节隔室特异性蛋白质 功能,核糖体生物合成,活性mRNA翻译和因此寿命。 为了解决这一假设,我们建议对蛋白质进行全局表征, 以及它对蛋白质稳定和衰老的影响。我们将联合收割机- 边缘遗传学和生物化学方法在C.和哺乳动物细胞来表征 衰老过程中蛋白质的核质分配(目标1),并最终揭示 新的核仁功能调节剂对阿尔茨海默病具有潜在的益处(Aim 2)。 这些拟议的研究是重要的,因为它们解决了与衰老相关的一个重要问题。 核质分配和核仁功能在生物体发育中的作用和调控 衰老我们的方法是创新的,因为我们使用C。线虫和哺乳动物细胞 快速鉴定特定的蛋白质翻译和蛋白质的分配与衰老的作用, 发现调节核仁和核糖体动力学的药理学策略, 预防老年痴呆症

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Louis Rene Lapierre其他文献

Louis Rene Lapierre的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Louis Rene Lapierre', 18)}}的其他基金

Investigating nucleo-cytoplasmic partitioning in Alzheimer's disease and aging
研究阿尔茨海默病和衰老中的核质分配
  • 批准号:
    10225453
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Regulation of the transcription factor HLH-30/TFEB in aging
转录因子 HLH-30/TFEB 在衰老过程中的调控
  • 批准号:
    9901412
  • 财政年份:
    2016
  • 资助金额:
    $ 19.81万
  • 项目类别:
Role of LIPL-4 in lysosomal lipolysis and aging
LIPL-4 在溶酶体脂肪分解和衰老中的作用
  • 批准号:
    9217535
  • 财政年份:
    2015
  • 资助金额:
    $ 19.81万
  • 项目类别:
Role of LIPL-4 in lysosomal lipolysis and aging
LIPL-4 在溶酶体脂肪分解和衰老中的作用
  • 批准号:
    8676622
  • 财政年份:
    2013
  • 资助金额:
    $ 19.81万
  • 项目类别:
Role of LIPL-4 in lysosomal lipolysis and aging
LIPL-4 在溶酶体脂肪分解和衰老中的作用
  • 批准号:
    8509547
  • 财政年份:
    2013
  • 资助金额:
    $ 19.81万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了